GenEvolutioN

GenEvolutioN is a private French contract research organization focused on in vitro genotoxicity, toxicology, and safety testing for regulated industries including pharmaceuticals, cosmetics, medical devices, food, chemicals, and agroscience. Founded in 2017 as a spin-off from the Sanofi and Covance preclinical center, the company operates GLP-compliant laboratories in Porcheville, France and emphasizes alternative human cell and reconstructed tissue models. Its service portfolio includes predictive and regulatory in vitro toxicology, mutagenicity and chromosomal damage assays, phototoxicity, sensitization testing, chemical analysis, consulting, and regulatory archiving. Rather than developing therapeutic drug candidates, GenEvolutioN provides specialized preclinical testing infrastructure and scientific expertise that help clients assess safety, support regulatory submissions, and reduce reliance on animal testing.